Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Investigating gait-responsive somatosensory cueing from a wearable device to improve walking in Parkinson's disease.

Li D. et al, (2023), Biomed Eng Online, 22

A programme evaluation of 'First Steps': A peer-conceived, developed and led self-management intervention for people after a Parkinson's diagnosis.

Collett J. et al, (2023), Clin Rehabil

Subthalamic nucleus shows opposite functional connectivity pattern in Huntington’s and Parkinson’s disease

Evangelisti S. et al, (2023), Brain Communications, 5

Investigation of the genetic aetiology of Lewy body diseases with and without dementia.

Wu L. et al, (2023), medRxiv

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease.

Martinez-Carrasco A. et al, (2023), NPJ Parkinsons Dis, 9

Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.

Street D. et al, (2023), Brain, 146, 3232 - 3242

Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.

Joza S. et al, (2023), Brain, 146, 3258 - 3272

Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study.

Joza S. et al, (2023), Alzheimers Dement

HLA in isolated REM sleep behavior disorder and Lewy body dementia.

Yu E. et al, (2023), Ann Clin Transl Neurol

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.

Foltynie T. et al, (2023), Brain, 146, 2717 - 2722

NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.

Somerville EN. et al, (2023), Neurobiol Aging, 127, 94 - 98

Reward insensitivity is associated with dopaminergic deficit in rapid eye movement sleep behaviour disorder

Barber TR. et al, (2023), Brain, 146, 2502 - 2511

B lymphocyte responses in Parkinson's disease and their possible significance in disease progression.

Scott KM. et al, (2023), Brain Commun, 5

Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications

Zou H. et al, (2023), Movement Disorders Clinical Practice

Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.

Gonzalez-Robles C. et al, (2023), J Parkinsons Dis, 13, 1013 - 1035

Neurofilament light levels predict clinical progression and death in multiple system atrophy.

Chelban V. et al, (2022), Brain, 145, 4398 - 4408

Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects.

Krohn L. et al, (2022), Nat Commun, 13

Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes

Pavelka L. et al, (2022), npj Parkinson's Disease, 8

Universal clinical Parkinson's disease axes identify a major influence of neuroinflammation.

Sandor C. et al, (2022), Genome Med, 14

Association between the LRP1B and APOE loci in the development of Parkinson's disease dementia.

Real R. et al, (2022), Brain

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?